Trial Profile
A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-arms Parallel Group Comparative Study of OPC-262 in Patients With Type 2 Diabetes (Phase 2/3 Study).
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Kyowa Hakko Kirin; Kyowa Kirin
- 22 Jun 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 22 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Oct 2009 New trial record